Core needle biopsy and immunohistochemistry (IHC) staining showed that the tumor was ER-positive (70%+), progesterone receptor (PR)-negative, HER2-negative (1+), and Ki67-positive (20%+). This evidence concerns the gene ERBB2 and neoplasm.